Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-12-23
1997-04-29
Lukton, David
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 3, 514 4, 514 7, 514 8, 514 19, 530331, 530322, 562561, A61K 3806
Patent
active
056249039
ABSTRACT:
Phosphoinositol-glycan-peptide with insulin-like action
Phosphoinositol-glycan-peptides obtainable by cleavage of adenosine 3',5'-cyclic monophosphate-binding protein, which contain glucosamine, galactose, mannose, inositol, phosphoric acid, ethanolamine and a peptide with the sequence Asx-Cys-Tyr, the preparation and use thereof for the treatment of diabetes mellitus and non-insulin-dependent diabetes are described.
REFERENCES:
patent: 4839466 (1989-06-01), Saltiel
patent: 4906468 (1990-03-01), Saltiel
Rodel, J. Bacterial 161, 7-12, 1985.
G.Muller & W. Bandlow, "Insulin Causes Lipolytic Cleavage and Endocytosis of a cAMP-Binding Protein from Plasma Membranes in Rat Adipocytes," Biol. Chem. Hoppe-Seyler, vol. 372(9), 718-19 (1991).
P. Bruni et al., "A Phospho-Oligosaccharide Can Reduce the Stimulatory Effect of Insulin on Glycolytic Flux in Human Fibroblasts," Biochem. and Biophys. Res. Comm., vol. 166(2), 765-71 (1990).
I.Varela et al., "Role of Glycosyl-Phospatidylinositols in Insulin Signalling," NATO ASI Series, vol. H44, 167-79 (1990).
G.Muller & W.Bandlow, "A cAMP-Binding Ectoprotein in the Yeast Saccharo-myces cerevisiae," Biol. Abstr. 93(2):AB-242 (1992).
M.Lisanti et al., "The Distribution of Glycosyl-Phosphatidylinositol Anchored Proteins is Differentially Regulated by Serum and Insulin", Biochem. and Biophys. Res. Comm., vol. 164(2), 824-32 (1989).
W.T. Garvey, "Insulin Resistance and Noninsulin-Dependent Diabetes Mellitus: Which Horse Is Pulling the Cart?", Diabetes/Metabolism Reviews, vol. 5, No. 8, (1989), pp. 727-742.
W.L. Roberts et al, "Structural Characterization of the Glycoinositol Phospholipid Membrane Anchor of Human Erythrocyte Acetylcholinesterase by Fast Atom Bombardment Mass Spectrometry", The Journal of Biological Chemistry, vol. 263, No. 35, (1988), pp. 18776-18784.
Roberts J. Biol Chem 263 18776, 1988.
Garvey Diabetes Metab Rev 5 727, 1989.
Gunter Muller et al., "An Amphitropic cAMP-Binding Protein in Yeast Mitochondria. 1. Synergistic Control of the Intramitochondrial Location by Calcium and Phospholipid," Biochemistry, vol. 28, (1989), pp. 9957-9967.
Muller Biochemistry 28, 9968-9973, 1989.
Muller Biological Chem Moppe Seylev 372, 718, 1991.
Muller Gunter
Mullner Stefan
Tripier Dominique
Heochst Aktiengesellschaft
Lukton David
LandOfFree
Phosphoinositol-glycan-peptide with insulin-like action does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphoinositol-glycan-peptide with insulin-like action, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphoinositol-glycan-peptide with insulin-like action will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-705649